This was a two-day event, taking place on 6th-7th November 2001 in the Arabella Sheraton, Munich. Over half the audience and presenting companies was from outside Germany, in particular with strong representation from Austrian, Israeli, Scandinavian and Swiss companies. Over 400 corporates, VCs, investment bankers and pharmas attended the conference.

Keynotes included presentations from:
3i • Apax Partners • Atlas Venture • Baker & MacKenzie • BankInvest Bio Venture • Bank Vontobel • Deutsche Venture Capital • Genzyme Corporation • HealthCap • JPMorgan Partners • Novartis Venture Fund • Schroder Venture Life Sciences •SWX Swiss Exchange • TVM Techno Venture Management • Warburg Pincus

Over 60 early stage to pre-IPO companies presented and sectors covered included:

  • Post-Genomics: PharmacoGenomics & Proteomics
  • Immunology / Oncology
  • Bioinformatics, SNP, Array Technology
  • Biomedical Engineering and Bio Materials
  • Medical Devices, Diagnostics
  • Therapeutics

Presenting companies included:
4SC AG • Ancile Pharmaceuticals, Inc. • Apovia AG • Applied Spectral Imaging, Ltd • AREVIA GmbH • ARPIDA Ltd • Astex Technology Ltd • atugen AG • AVIDIS S.A. • BioImage A/S • BioWisdom Ltd • CardiacAssist, Inc. • CNSystems • Medizintechnik GmbH • Contral Pharma Ltd • CureTech Ltd • Cyclacel Limited • Diabetogen Biosciences, Inc • Epigenomics AG • ESBATech AG • Ester NeuroSciences Ltd • Exiqon A/S • febit GmbH • FibroGen Europe Oyj • Frimorfo Ltd • FRIZ Biochem GmbH • GeneFormatics, Inc • GenOdyssee S.A. • Genomic Profiling Systems, Inc. • GlycArt Biotechnology Ltd • Graffinity Pharmaceutical Design GmbH • Hormos Medical Ltd • IDgene Pharmaceuticals Ltd • Igeneon AG • InGene, Institut für genetische Medizin, GmbH • Investigen, Inc. • Lipoxen Technologies Ltd • Lorantis Limited • Medgenics, Inc. • Megamedics GmbH • Metris Therapeutics Ltd • Mologen Holding AG • MTM Laboratories AG • M.T.R.E Advanced Technologies Ltd • NextGen Sciences Ltd • Optimata Ltd • Oxagen Limited • PAION GmbH • Pantheco A/S • PhytoCeutica, Inc. • PIERIS Proteolab AG • Polyheal Ltd • QuantomiX Ltd • Questcor Pharmaceuticals, Inc. • R.E.D. Laboratories NV • RiboTargets Ltd • Scimagix, Inc. • SEDAC Therapeutics S.A •Sense proteomic Ltd • Sol-Gel Technologies • Speedel Holding AG • SWITCH BIOTECH AG • The Genetics Company, Inc. • Venture Valuation • VerCell Biotechnology BV • Xerion Pharmaceuticals AG • YM BioSciences Inc.

The Forum was supported by several international biotech organisations including BioM - Prof. Dr. Horst Domdey (Chairperson), DIB (German Biotechnology Association), BioTOP, BioIsrael and SECA.

Click here for the full Agenda or to download a pdf of the full programme click here.